Full Text
Ischemic stroke represents a major neurological emergency characterized by sudden interruption of cerebral blood circulation leading to focal brain ischemia and progressive neuronal damage. The disorder accounts for the majority of cerebrovascular diseases worldwide and remains one of the primary causes of mortality, chronic disability, cognitive decline, and socioeconomic burden. Ischemic stroke occurs when cerebral arteries become obstructed due to thrombosis, embolism, or systemic hypoperfusion, resulting in inadequate delivery of oxygen and glucose to brain tissue. Neurons are highly sensitive to ischemia because of their elevated metabolic requirements and limited energy reserves; consequently, even brief interruption of cerebral perfusion initiates complex neurophysiological and biochemical cascades resulting in irreversible neuronal injury. Contemporary understanding of ischemic stroke emphasizes the importance of the ischemic cascade involving ATP depletion, membrane depolarization, excessive glutamate release, calcium influx, mitochondrial dysfunction, oxidative stress, inflammatory activation, blood-brain barrier disruption, apoptosis, and necrosis. The ischemic core represents an area of severe irreversible tissue injury, whereas surrounding penumbral regions contain functionally impaired but potentially salvageable neurons if timely reperfusion is achieved. Neuroinflammatory processes involving microglial activation, cytokine release, leukocyte infiltration, and endothelial dysfunction significantly contribute to secondary neuronal injury and progression of ischemic damage. Cerebral edema, increased intracranial pressure, and impaired autoregulation additionally exacerbate neurological deterioration during acute stroke progression. Clinical manifestations vary according to vascular territory and extent of cerebral injury and may include unilateral weakness, facial asymmetry, aphasia, dysarthria, visual deficits, sensory impairment, ataxia, altered consciousness, and cognitive dysfunction. Early diagnosis and rapid restoration of cerebral perfusion remain critically important because therapeutic effectiveness is strongly dependent on time from symptom onset. Modern neuroimaging techniques including computed tomography, magnetic resonance imaging, diffusion-weighted imaging, perfusion studies, and vascular angiography significantly improve identification of ischemic lesions and selection of patients for reperfusion therapy. Intravenous thrombolysis and mechanical thrombectomy have revolutionized acute ischemic stroke management through restoration of cerebral blood flow and reduction of infarct progression. Advances in neurophysiology, neuroplasticity, regenerative medicine, stem cell therapy, neuromodulation, and rehabilitation science continue to improve understanding of neuronal recovery mechanisms and functional reorganization following ischemic injury. Contemporary stroke management increasingly requires interdisciplinary integration of neurology, neuroradiology, intensive care, rehabilitation medicine, vascular surgery, neurophysiology, and molecular neuroscience to optimize acute treatment and long-term functional recovery.
2. Materials and Methods
This study was conducted using clinical, neurological, neurophysiological, and radiological evaluation of patients diagnosed with acute ischemic stroke between 2020 and 2025. Comprehensive neurological assessment included evaluation of motor deficits, sensory disturbances, cranial nerve function, speech abnormalities, cognitive impairment, coordination disorders, and level of consciousness. Stroke severity was assessed using standardized neurological scales including the National Institutes of Health Stroke Scale and functional outcome indexes. Diagnostic procedures included computed tomography, magnetic resonance imaging, diffusion-weighted imaging, perfusion studies, Doppler ultrasonography, electroencephalography, laboratory biomarker analysis, and vascular angiography for assessment of cerebral perfusion and vascular occlusion. Neurophysiological evaluation focused on cortical activity, neuronal conduction, cerebral autoregulation, and ischemia-related functional abnormalities. Therapeutic interventions including intravenous thrombolysis, mechanical thrombectomy, antiplatelet therapy, anticoagulation, neuroprotective agents, intensive care management, neuromodulation techniques, and multidisciplinary rehabilitation programs were analyzed comparatively to determine clinical effectiveness and long-term neurological outcomes.
Comprehensive clinical evaluation demonstrated that ischemic stroke most frequently presented with acute unilateral motor weakness, facial asymmetry, speech impairment, sensory deficits, visual disturbances, and impaired coordination corresponding to localization of cerebral ischemic injury. Neuroimaging studies revealed cerebral infarction predominantly within middle cerebral artery territories accompanied by perfusion deficits and vascular occlusion. Diffusion-weighted magnetic resonance imaging effectively identified early ischemic lesions and allowed differentiation between ischemic core and salvageable penumbral tissue. Neurophysiological assessment demonstrated disruption of cortical electrical activity, impaired neuronal conduction, altered cerebral autoregulation, and reduction of functional connectivity within affected brain regions. Elevated inflammatory biomarkers, oxidative stress markers, and endothelial dysfunction indicators were observed during the acute phase of ischemic stroke. Patients receiving early intravenous thrombolysis and mechanical thrombectomy demonstrated significantly improved cerebral reperfusion, reduced infarct volume, lower neurological deficit severity, and better functional recovery compared with delayed or conservative treatment groups. Intensive neurocritical care and stabilization of systemic physiological parameters contributed to reduction of secondary neuronal injury and cerebral edema. Early rehabilitation programs involving physiotherapy, speech therapy, occupational therapy, neuromuscular stimulation, and cognitive rehabilitation significantly improved motor recovery, speech function, coordination, and daily living activities. Neuroplasticity-related functional reorganization and partial restoration of cortical activity were observed during long-term rehabilitation, particularly in patients receiving comprehensive multidisciplinary therapy. Patients undergoing individualized rehabilitation demonstrated improved neurological recovery, reduced disability, enhanced cognitive function, and greater quality of life during follow-up evaluation.
The findings confirm that ischemic stroke is a highly complex neurovascular disorder involving multifactorial neurophysiological mechanisms leading to progressive neuronal injury and functional impairment. The ischemic cascade remains the central pathophysiological process responsible for cerebral tissue damage and includes metabolic failure, excitotoxicity, oxidative stress, inflammatory activation, mitochondrial dysfunction, and apoptosis. Excessive glutamate release and calcium influx represent critically important mechanisms contributing to neuronal depolarization, enzymatic activation, free radical production, and irreversible cellular destruction. Neuroinflammation significantly amplifies secondary injury through activation of microglia, cytokine production, endothelial dysfunction, and blood-brain barrier disruption. The concept of ischemic penumbra remains fundamental in modern stroke management because timely reperfusion therapy may preserve viable neuronal tissue and substantially improve neurological outcomes. The study additionally demonstrates that rapid diagnosis and early therapeutic intervention are critically important determinants of survival and functional recovery. Contemporary neuroimaging technologies significantly improve identification of ischemic lesions, evaluation of cerebral perfusion, and selection of candidates for thrombolytic and endovascular treatment. Mechanical thrombectomy represents one of the most important advancements in acute stroke management and provides substantial benefit in patients with large-vessel occlusion. Neuroplasticity plays a major role in post-stroke recovery through cortical reorganization, synaptic remodeling, and adaptive functional compensation within surviving neuronal networks. Early multidisciplinary rehabilitation therefore remains essential for optimization of motor, cognitive, speech, and psychosocial recovery. Despite substantial progress in stroke medicine, several clinical challenges remain significant including delayed hospital presentation, limited therapeutic windows, hemorrhagic transformation, recurrent stroke risk, cognitive impairment, and incomplete neurological recovery. Future scientific research increasingly focuses on neuroprotective pharmacology, stem cell therapy, regenerative neuroscience, artificial intelligence-assisted diagnosis, personalized rehabilitation, brain-computer interfaces, and advanced neuromodulation technologies aimed at improving neuronal preservation and long-term functional outcomes. Integration of neurology, neuroradiology, neurophysiology, rehabilitation medicine, molecular neuroscience, and critical care therefore remains essential for advancement of ischemic stroke treatment and reduction of global neurological disability.
Ischemic stroke is a severe neurovascular disorder characterized by interruption of cerebral blood flow leading to neuronal ischemia, metabolic failure, neuroinflammation, excitotoxicity, and progressive neurological dysfunction. Neurophysiological mechanisms including glutamate-mediated excitotoxicity, oxidative stress, inflammatory activation, mitochondrial injury, and cerebral autoregulatory dysfunction play central roles in progression of ischemic brain damage. Early diagnosis utilizing advanced neuroimaging and rapid implementation of reperfusion therapy significantly improve cerebral perfusion and reduce irreversible neuronal injury. Contemporary treatment approaches including thrombolysis, mechanical thrombectomy, neurocritical care, neuroprotective strategies, and multidisciplinary rehabilitation substantially improve neurological recovery and long-term quality of life. Continuous advancement in regenerative medicine, neuroplasticity research, stem cell therapy, neuromodulation, and personalized neurorehabilitation will further improve therapeutic effectiveness and functional outcomes in ischemic stroke management.
[1] Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischemic stroke. Trends Neurosci. 1999;22(9):391–397.
[2] Campbell BCV, De Silva DA, Macleod MR, et al. Ischaemic stroke. Nat Rev Dis Primers. 2019;5(1):70.
[3] Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of acute ischemic stroke. Stroke. 2019;50(12):e344–e418.
[4] Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron. 2010;67(2):181–198.
[5] Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci. 2003;4(5):399–415.
[6] Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371(9624):1612–1623.
[7] Saver JL. Time is brain—quantified. Stroke. 2006;37(1):263–266.
[8] Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischemic stroke. N Engl J Med. 2015;372(24):2285–2295.
[9] Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase after acute ischemic stroke. N Engl J Med. 2008;359(13):1317–1329.
[10] Iadecola C, Anrather J. The immunology of stroke. Nat Med. 2011;17(7):796–808.
[11] Feigin VL, Norrving B, Mensah GA. Global burden of stroke. Circ Res. 2017;120(3):439–448.
[12] Cramer SC. Repairing the human brain after stroke. Ann Neurol. 2008;63(3):272–287.
[13] Krakauer JW, Carmichael ST. Broken movement: the neurobiology of motor recovery after stroke. MIT Press; 2017.
[14] Chamorro Á, Dirnagl U, Urra X, Planas AM. Neuroprotection in acute stroke. Lancet Neurol. 2016;15(8):869–881.
[15] Bernhardt J, Hayward KS, Kwakkel G, et al. Agreed definitions and a shared vision for new standards in stroke recovery research. Int J Stroke. 2017;12(5):444–450.
[16] Katan M, Luft A. Global burden of stroke. Semin Neurol. 2018;38(2):208–211.
[17] World Health Organization. Stroke and cerebrovascular diseases fact sheet. Geneva: WHO; 2025.
[18] American Heart Association. Heart disease and stroke statistics—2025 update. Circulation. 2025;151(8):e347–e913.
[19] Med1.uz. Ishemik insultning neyrofiziologik mexanizmlari. Available from: https://med1.uz/articles/nevrologiya/neyrofiziologiya
[20] Med1.uz. Miya qon aylanishining o‘tkir buzilishlari. Available from: https://med1.uz/articles/nevrologiya/ishemik-insult
[21] Med1.uz. Trombolitik terapiya va zamonaviy insult davolash. Available from: https://med1.uz/articles/nevrologiya/trombolizis
[22] Med1.uz. Neyroprotektiv terapiyaning klinik ahamiyati. Available from: https://med1.uz/articles/farmakologiya/neyroproteksiya
[23] Med1.uz. Insult diagnostikasida neyrovizualizatsiya usullari. Available from: https://med1.uz/articles/diagnostika/neyrovizualizatsiya
[24] Med1.uz. Insultdan keyingi reabilitatsiya va neyroplastiklik. Available from: https://med1.uz/articles/reabilitatsiya/neyroplastiklik
[25] Med1.uz. Nevrologik bemorlarda intensiv terapiya tamoyillari. Available from: https://med1.uz/articles/reanimatsiya/intensiv-terapiya
[26] Med1.uz. Miya qon tomir kasalliklari profilaktikasi. Available from: https://med1.uz/articles/nevrologiya/profilaktika